Form 4 for OMDA Omada Health, Inc.
Accepted 2026-01-14 00:00:00 ET · period of report 2026-01-12 · accession 0001610717-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-14 | 2026-01-12+ | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $2.55 | +271.3K | 167.4K | New | +$691.8K |
| DM | 2026-01-14 | 2026-01-12+ | OMDA | Duffy Sean P. | CEO, Dir | S - Sale+OE | $15.65 | -271.3K | 217.1K | -56% | -$4.25M |
| DM | 2026-01-14 | 2026-01-12+ | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $0.00 | -271.3K | 40.8K | -87% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-12 | M | A | 230,479 | $2.55 | 357,123 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-13 | S | D | 40,796 | $15.95 | 126,644 | D | — | — | (F1) Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026. (F4) This transaction was executed in multiple trades at prices ranging from $15.61 to $16.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-01-12 | S | D | 90,490 | $15.99 | 126,644 | D | — | — | (F1) Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026. (F3) This transaction was executed in multiple trades at prices ranging from $15.85 to $16.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-01-12 | S | D | 139,989 | $15.35 | 217,134 | D | — | — | (F1) Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $14.85 to $15.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-01-13 | M | A | 40,796 | $2.55 | 167,440 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-01-13 | M | D | 40,796 | $0.00 | 0 | D | $2.55 · — to 2026-01-27 | 40,796 Common Stock | (F6) The option is fully vested and exercisable. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-01-12 | M | D | 230,479 | $0.00 | 40,796 | D | $2.55 · — to 2026-01-27 | 230,479 Common Stock | (F6) The option is fully vested and exercisable. |